Accessibility Menu
MediPharm Labs logo

MediPharm Labs

(OTC) MEDIF

Current Price$0.06
Market Cap$24.09MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-97%
5 Year-82%
1 Year+21%
1 Month+16%
MediPharm Labs last closing stock price
MetricPriceDate
Last closeUSD 0.062026-07-16
MediPharm Labs stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+20.74%USD 0.052026-07-09
1 month+16.2%USD 0.052026-06-16
3 month+23.4%USD 0.052026-04-17
Year to date+20.98%USD 0.052025-12-31
1 year+20.98%USD 0.052025-07-16
3 year+39.59%USD 0.042023-07-17
5 year-82.29%USD 0.352021-07-16
Since inception-96.67%USD 1.702018-10-05

MediPharm Labs Financials at a Glance

Market Cap

$24.09MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$43.30M

Net Income (TTM)

-CA$8.75M

EPS (TTM)

-$0.02

P/E Ratio

-3.75

Dividend

$0.00

Beta (Volatility)

0.63 (Low)

Price

$0.06

Volume

203,107

Open

$0.06

Previous Close

$0.06

Daily Range

$0.06 - $0.06

52-Week Range

$0.04 - $0.08

Estimated Earnings Date

Aug 14, 2024

MEDIF News

Marijuana Cannabis Pot Weed Trimmed Buds Atop Cash Bills Money Getty

10 Pot Stocks Expected to Grow Sales by 60% (or More) in 2021

Sean WilliamsJul 18, 2020
Cannabis extract in a jar

MediPharm Sinks by Over 14% on Q1 Results

Eric VolkmanJun 18, 2020
GettyImages-1062359554

3 Pot Stocks to Stay Miles Away From

James HalleyJun 14, 2020
Cannabis extract in a jar

MediPharm Australia Subsidiary Signs Its First European Private-Label Supply Deal

Eric VolkmanMay 15, 2020
Marijuana Dispensary Cannabis Weed Pot Store Bud Oil Getty

The 9 Best Marijuana Stocks in April

Sean WilliamsMay 4, 2020
Stopwatch Time to Buy Stock Market Correction Getty

10 Brand-New Stocks I Bought During the Stock Market Crash

Sean WilliamsApr 14, 2020
Cannabis Flower Bud Weed Pot Marijuana Grow Facility Greenhouse Legal Canada Getty

4 Canadian Pot Stocks Expected to Be Profitable in 2021

Sean WilliamsApr 11, 2020
Flowering Marijuana Plant Cannabis Pot Weed Grow Getty

5 Pot Stocks That Can Survive the Coronavirus Crash

Sean WilliamsMar 29, 2020
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MediPharm Labs

MediPharm Labs Corp. operates as a pharmaceutical firm specializing in the manufacturing and distribution of pharmaceutical-grade cannabis oils, concentrates, and advanced derivative products. The company has a significant market presence in Canada, Australia, Germany, and other international territories.

Products and Services
  • Manufacturing of pharmaceutical-grade cannabis oils and concentrates
  • Advanced cannabinoid-based derivative products
  • GMP-compliant sourcing, packaging, and distribution services for cannabis flower
Growth Outlook
  • Revenue increased to CAD 8.99 million in Q1 2026
  • Gross profit margin improved to 38.7% in Q1 2026
  • Strong market demand for cannabinoid-based products across multiple regions
Financial Highlights
  • Trailing twelve months revenue of CAD 43.5 million
  • Current ratio of 3.02 indicates strong liquidity position
  • Cash and cash equivalents of CAD 9.89 million as of Q1 2026
MediPharm Labs Corp. has established itself as a key player in the pharmaceutical cannabis industry, focusing on high-quality products and compliance with regulatory standards. The recent quarterly results indicate a positive trend in revenue and gross profit margins, reflecting the company's ability to adapt to market demands. The strong liquidity position, as evidenced by the current ratio, suggests that the company is well-positioned to manage its short-term obligations effectively. With a solid foundation and a growing market, MediPharm Labs Corp. presents an intriguing opportunity for potential investors interested in the evolving cannabis sector.
AI Generated • Jun 27, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

127

CEO

Greg Hunter, MBA, CPA

Website

www.medipharmlabs.com

Headquarters

Barrie, ON L4N 2L1, CA

MEDIF Financials

Key Financial Metrics (TTM)

Gross Margin

30.63%

Operating Margin

-20.37%

Net Income Margin

-20.21%

Return on Equity

-23.55%

Return on Capital

-24.00%

Return on Assets

-20.05%

Earnings Yield

-26.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$24.09MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

424.86M

Volume

203.11K

Avg. Volume

76.40K

Financials (TTM)

Gross Profit

CA$13.13M

Operating Income

-CA$8.70M

EBITDA

-CA$6.98M

Operating Cash Flow

-CA$3.23M

Capital Expenditure

-CA$59.00K

Free Cash Flow

-CA$3.29M

Cash & ST Invst.

CA$9.89M

Total Debt

CA$18.05K

MediPharm Labs Performance Analysis

MediPharm Labs annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 16,988,855-1.9%
20232023-12-31CAD 24,496,05044.2%
20242024-12-31CAD 30,629,32625.0%
20252025-12-31CAD 32,293,9745.4%
MediPharm Labs sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-309.3%
Q32025-09-30-3.0%
Q42025-12-31-3.5%
Q12026-03-31-18.7%
MediPharm Labs annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.08-52.4%
20232023-12-31CAD -0.03-67.9%
20242024-12-31CAD -0.02-28.5%
20252025-12-31CAD -0.01-26.2%
MediPharm Labs sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-911.1%
Q32025-09-3042.9%
Q42025-12-3111.5%
Q12026-03-3156.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$8.99M

-16.8%

Gross Profit

CA$3.48M

-16.8%

Gross Margin

38.71%

N/A

Market Cap

$24.09MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$189.68K

N/A

Employees

127

N/A

Net Income

-CA$869.24K

-124.6%

EBITDA

-CA$467.20K

-965.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$9.89M

+14.7%

Total Debt

CA$18.05K

-85.6%

Accounts Receivable

CA$6.55M

-15.9%

Inventory

CA$8.49M

-19.8%

Long Term Debt

CA$0.00

-100.0%

Short Term Debt

CA$36.05K

-61.7%

Return on Assets

-20.05%

N/A

Return on Invested Capital

-25.12%

N/A

Free Cash Flow

-CA$781.01K

+74.4%

Operating Cash Flow

-CA$780.01K

+74.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RVXCFResverlogix Corp.
$0.08+7.05%
GBLPGlobal Pharmatech, Inc.
$0.08+0.00%
AVCNFAvicanna Inc.
$0.09-1.74%
CWBHFCharlotte's Web Holdings, Inc.
$0.25+0.20%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$15.60-0.00%
ATAIAtaiBeckley
$7.15+0.33%
NOKNokia
$10.38-0.08%
SOFISoFi Technologies
$17.32-0.03%

Questions About MEDIF

What is the current price of MediPharm Labs?

MediPharm Labs is trading at $0.06 per share.

What is the 52-week range for MediPharm Labs?

Over the past 52 weeks, MediPharm Labs has traded between $0.04 and $0.08.

How much debt does MediPharm Labs have?

As of the most recent reporting period, MediPharm Labs reported total debt of CA$12.90K.

How much cash does MediPharm Labs have on hand?

MediPharm Labs reported CA$7.07M in cash and cash equivalents in its most recent financial results.

What is MediPharm Labs’s dividend yield?

MediPharm Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services